19 Countries Have Submitted Bids To Host The EMA Post-Brexit
Formal offers to host the European Medicines Agency were received from 19 countries by the deadline of July 31. The European Commission will now begin assessing the bids on the basis of six criteria, with a final decision expected in November.
You may also be interested in...
A stakeholder event being organized by the Irish regulatory body, the HPRA, will hear views on the implications and risks of Brexit from associations representing the originator and generic/biosimilar industries, as well as the head of the HPRA’s task force on Brexit.
EU member state Austria has lost its only two medtech notified bodies, which is ringing alarm bells for local medtech industry advocates who fear there will be a loss of momentum and profile for the national medtech ecosystem.
Some countries in eastern Europe say that they should host the European Medicines Agency in order to respect the criterion of “geographical spread.” But many in western Europe say this principle should apply only to new agencies and that the criterion of business continuity at the EMA should take precedence.